Overview

A Study of CAR-T Cells in Subjects With Systemic Lupus Erythematosus

Status:
NOT_YET_RECRUITING
Trial end date:
2027-12-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of CAR-T cell therapy in Subjects with SLE.
Phase:
NA
Details
Lead Sponsor:
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Treatments:
Immunotherapy, Adoptive